UK court upholds CMA hydrocortisone pricing findings after decade-long NHS cost surge

The Court of Appeal backed findings that Auden Mckenzie and Actavis UK charged excessive and unfair prices, while sending penalty appeals back to the Competition Appeal Tribunal for reconsideration.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.